Featured Article
Untangling the evolution of cancer
Here at the ICR, Professor Mel Greaves applies evolutionary thinking to illuminate how cancers work.
Prostate cancer drug benefits earlier-stage disease
11 Dec 2012
Prostate cancer drug benefits earlier-stage disease
The ICR welcomes £100m investment in high-tech genome profiling for cancer patients.
10 Dec 2012
The ICR welcomes £100m Government investment in high-tech genome profiling for cancer patients.
Fewer, bigger doses of radiotherapy benefit breast cancer patients
06 Dec 2012
Women diagnosed with breast cancer can benefit from receiving fewer but higher doses of radiotherapy than is the international standard, according to long-term follow-up data of a major UK-wide trial led by the ICR.
Kidney cancer genetic risk discovery
05 Dec 2012
Scientists at the ICR have found a new genetic variation which increases a person’s risk of developing the most common type of kidney cancer.
See 2012 Press Release Archive |
